FDA OK's Central Precocious Puberty Tx; Longer Quarantine With Obesity?

]]>(MedPage Today) -- The FDA approved a 6-month injectable leuprolide acetate (Fensolvi) for pediatric patients with central precocious puberty, said drugmaker Tolmar Pharmaceuticals.Should people with obesity quarantine longer after coronavirus...